These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8723299)

  • 1. Time-dependent effects of a haloperidol challenge on energy metabolism in the normal human brain.
    Bartlett EJ; Brodie JD; Simkowitz P; Dewey SL; Rusinek H; Volkow ND; Wolf AP; Smith G; Wolkin A; Cancro R
    Psychiatry Res; 1996 Mar; 60(2-3):91-9. PubMed ID: 8723299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.
    Holcomb HH; Cascella NG; Thaker GK; Medoff DR; Dannals RF; Tamminga CA
    Am J Psychiatry; 1996 Jan; 153(1):41-9. PubMed ID: 8540590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients.
    Bartlett EJ; Brodie JD; Simkowitz P; Schlösser R; Dewey SL; Lindenmayer JP; Rusinek H; Wolkin A; Cancro R; Schiffer W
    Am J Psychiatry; 1998 Mar; 155(3):337-43. PubMed ID: 9501742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects.
    Bartlett EJ; Brodie JD; Simkowitz P; Dewey SL; Rusinek H; Wolf AP; Fowler JS; Volkow ND; Smith G; Wolkin A
    Am J Psychiatry; 1994 May; 151(5):681-6. PubMed ID: 8166309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of acute and chronic administration of haloperidol and clozapine using [3H] 2-deoxyglucose metabolic mapping.
    Wotanis J; Hanak SE; Wettstein JG; Black MD
    Schizophr Res; 2003 Jun; 61(2-3):195-205. PubMed ID: 12729871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose raclopride spares the extrapyramidal system in rat brain from metabolic effects.
    Tarazi FI; Shirakawa O; Tamminga CA
    Eur J Pharmacol; 1993 Feb; 232(1):71-7. PubMed ID: 8096189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic effects on regional brain metabolism in first episode schizophrenics.
    Cleghorn JM; Szechtman H; Garnett ES; Brown GM; Nahmias C; Szechtman B; Kaplan R; Franco S
    Schizophr Res; 1991 Oct; 5(3):208-9. PubMed ID: 1684720
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of dopamine metabolism with local cerebral glucose utilization in rat brain following the administration of haloperidol decanoate.
    Kurachi M; Yasui S; Shibata R; Murata M; Hagino H; Kurachi T; Tanii Y; Kurata K
    Biol Psychiatry; 1994 Jul; 36(2):110-7. PubMed ID: 7948443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia.
    Bartlett EJ; Barouche F; Brodie JD; Wolkin A; Angrist B; Rotrosen J; Wolf AP
    Psychiatry Res; 1991 May; 40(1):11-20. PubMed ID: 1946838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography and subcortical glucose metabolism in schizophrenia.
    Resnick SM; Gur RE; Alavi A; Gur RC; Reivich M
    Psychiatry Res; 1988 Apr; 24(1):1-11. PubMed ID: 2899331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D2-dopamine receptor occupancy differs between patients with and without extrapyramidal side effects.
    Scherer J; Tatsch K; Schwarz J; Oertel WH; Konjarczyk M; Albus M
    Acta Psychiatr Scand; 1994 Oct; 90(4):266-8. PubMed ID: 7831996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of chronic administration of haloperidol and pimozide on dopamine metabolism in the rat brain.
    Karolewicz B; Antkiewicz-Michaluk L; Michaluk J; Vetulani J
    Eur J Pharmacol; 1996 Oct; 313(3):181-6. PubMed ID: 8911913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients.
    Cleghorn JM; Szechtman H; Garnett ES; Nahmias C; Brown GM; Kaplan RD; Szechtman B; Franco S
    Psychiatry Res; 1991 Oct; 40(2):135-53. PubMed ID: 1763143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of 0.8 g.kg ethanol on cerebral metabolism and mood in normal volunteers.
    de Wit H; Metz J; Cooper M
    NIDA Res Monogr; 1989; 95():450. PubMed ID: 2641027
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Angrist B; Hitzemann R; Lieberman J; Pappas N
    Am J Psychiatry; 1997 Jan; 154(1):50-5. PubMed ID: 8988958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia.
    van Gorp WG; Mandelkern MA; Gee M; Hinkin CH; Stern CE; Paz DK; Dixon W; Evans G; Flynn F; Frederick CJ
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):280-7. PubMed ID: 1498579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain glucose metabolism in violent psychiatric patients: a preliminary study.
    Volkow ND; Tancredi LR; Grant C; Gillespie H; Valentine A; Mullani N; Wang GJ; Hollister L
    Psychiatry Res; 1995 Nov; 61(4):243-53. PubMed ID: 8748468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebellar metabolic activation by delta-9-tetrahydro-cannabinol in human brain: a study with positron emission tomography and 18F-2-fluoro-2-deoxyglucose.
    Volkow ND; Gillespie H; Mullani N; Tancredi L; Grant C; Ivanovic M; Hollister L
    Psychiatry Res; 1991 May; 40(1):69-78. PubMed ID: 1658842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose metabolism in the caudate nuclei of patients with eating disorders, measured by PET.
    Krieg JC; Holthoff V; Schreiber W; Pirke KM; Herholz K
    Eur Arch Psychiatry Clin Neurosci; 1991; 240(6):331-3. PubMed ID: 1831664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.